Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Exclusion Criteria

• •1. Patients with recurrent rectal cancer or a history of pelvic radiation
• •2. Patients with a history of inflammatory bowel disease
• •3. Patients with a history of pneumonitis or interstitial lung disease
• •4. Patients with concurrent autoimmune disease or a history of chronic or recurrent autoimmune disease
• •5. Patients requiring treatment with systemic corticosteroids or immunosuppressants or who have received these treatments within 14 days before enrollment in the study
• •6. Patients with a history of thyroid dysfunction
• •7. Patients with a history or finding of cardiovascular risk
• •8. Patients who are positive for any of the following: HIV1 antibody, HIV2 antibody, HTLV1 antibody
• •9. Patients who are pregnant or lactating or who may be pregnant
• •10. Patients with significant unstable mental diseases or other medical diseases that may interfere with the safety of the subjects, obtaining informed consent, or compliance with the procedures for the clinical study